These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2857523)

  • 1. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy.
    Anderson JL; Lutz JR; Gilbert EM; Sorensen SG; Yanowitz FG; Menlove RL; Bartholomew M
    Am J Cardiol; 1985 Feb; 55(4):471-5. PubMed ID: 2857523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta receptor blockers in dilated cardiomyopathy (clinical aspects)].
    Sigmund M; Reineke T
    Z Kardiol; 1992; 81 Suppl 4():65-70. PubMed ID: 1363261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
    Engelmeier RS; O'Connell JB; Walsh R; Rad N; Scanlon PJ; Gunnar RM
    Circulation; 1985 Sep; 72(3):536-46. PubMed ID: 3893793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.
    Gilbert EM; O'Connell JB; Bristow MR
    Heart Vessels Suppl; 1991; 6():29-39. PubMed ID: 1687924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy.
    Anderson JL; Gilbert EM; O'Connell JB; Renlund D; Yanowitz F; Murray M; Roskelley M; Mealey P; Volkman K; Deitchman D
    J Am Coll Cardiol; 1991 May; 17(6):1373-81. PubMed ID: 1673132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of beta-adrenergic blockade in dilated cardiomyopathy--a questionnaire study in Japan.
    Matsumori A; Tominaga M; Handa S; Fukuchi Y; Kitabatake A; Matsuo H; Matsuo S; Mihune J; Nakano T; Nobuoka S
    Heart Vessels Suppl; 1991; 6():6-10. PubMed ID: 1687925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
    Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
    De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
    Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
    Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic treatment of dilated cardiomyopathy by beta blocking agents. Clinical and hemodynamic follow-up].
    Cucchini F; Compostella L; Papalia D; de Domenico R; Iavernaro A; Zeppellini R
    G Ital Cardiol; 1988 Oct; 18(10):835-42. PubMed ID: 2907743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group.
    Di Lenarda A; De Maria R; Gavazzi A; Gregori D; Parolini M; Sinagra G; Salvatore L; Longaro F; Bernobich E; Camerini F
    Heart; 1998 Apr; 79(4):337-44. PubMed ID: 9616339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
    Kantor PF; Abraham JR; Dipchand AI; Benson LN; Redington AN
    J Am Coll Cardiol; 2010 Mar; 55(13):1377-84. PubMed ID: 20338500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Waagstein F; Bristow MR; Swedberg K; Camerini F; Fowler MB; Silver MA; Gilbert EM; Johnson MR; Goss FG; Hjalmarson A
    Lancet; 1993 Dec; 342(8885):1441-6. PubMed ID: 7902479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.